B3GAT1 and non-small cell lung carcinoma: An independent validation cohort of patients with NSCLC revealed that the frequency of baseline CD57+CD8+ T cells was higher in DCB group and had high sensitivity and specificity for predicting the responsiveness to ICIs, with a determined cutoff value of 12.85%.